Successful treatment of human granulocytic ehrlichiosis in children using rifampin.

Peter J. Krause, Cathy L. Corrow, Johan S. Bakken

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Abstract

Human granulocytic ehrlichiosis (HGE) is an emerging tick-borne infectious disease caused by Anaplasma phagocytophilum. Clinical features include a flu-like illness that usually resolves within 1 week. More serious infection may occur that requires hospital admission or culminates in death. Doxycycline is the treatment of choice for HGE but may cause permanent staining of teeth in children younger than 8 years of age. We report successful treatment of HGE with rifampin in 2 children, 4 and 6 years old. A course of rifampin for 5 to 7 days should be considered in children younger than 8 years of age who experience non-life-threatening A phagocytophilum infection.

Original languageEnglish (US)
Pages (from-to)e252-253
JournalPediatrics
Volume112
Issue number3 Pt 1
DOIs
StatePublished - Sep 2003

Fingerprint Dive into the research topics of 'Successful treatment of human granulocytic ehrlichiosis in children using rifampin.'. Together they form a unique fingerprint.

Cite this